Skip to content
The Policy VaultThe Policy Vault

Recorlev (levoketoconazole)Medica

Endogenous Cushing’s syndrome

Initial criteria

  • age ≥ 18 years
  • Patient has hypercortisolemia
  • Patient meets ONE of the following (i, ii, OR iii): i. According to the prescriber, the patient is not a candidate for surgery or surgery has not been curative; OR ii. Patient is awaiting surgery for endogenous Cushing’s syndrome; OR iii. Patient is awaiting therapeutic response after radiotherapy for endogenous Cushing’s syndrome
  • Patient has tried ketoconazole tablets
  • Medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of endogenous Cushing’s syndrome

Approval duration

1 year